Skip to content

Study · Animal study (in vivo) · rat · 1995

5 results

[The characteristics of the anxiolytic action of taftsin and its analog TP-7 on behavior and serotonin metabolism in the brain of rats with chronic deprivation of serotoninergic system activity].

Seredenin SB, Semenova TP, Kozlovskaia MM, Medvinskaia NI, Nezovibat'ko VN

Eksperimental'naia i klinicheskaia farmakologiia1 Nov 1995

PMID8704608 (opens in a new tab)PepBankPUB-08704608

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with chronic serotonergic deprivation, intracutaneous TP-7 (Selank) weakened the perception of stress situations, as did taftcine.

    In plain wordsIn rats with low brain serotonin, Selank weakened the perception of stress. Taftcine did the same.

    Peptide
    Selank
    Outcome
    DecreasePerception of stress situations
    Study

    ratn = 95

    rats with chronic deprivation of serotonergic activity (neonatal 5,7-dihydroxytriptamine)
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    300 micrograms/kg · intracutaneousAs given in this study (rat).

    Source sentences

    Summary
    weakening perception of stress situations
    1 context sentence
    Summary · context
    The effect of taftcine (Thr-Lys-Pro-Arg) and its analog TP-7 (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on rat behavior and serotonin brain exchange was studied in 95 adult male Wistar rats neonatally administered with 5,7-dihydroxytriptamine.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats with chronic serotonergic deprivation, TP-7 (Selank) increased the stability of investigation behavior, as did taftcine.

    In plain wordsIn rats with low brain serotonin, Selank made exploring behaviour more stable. Taftcine did the same.

    Peptide
    Selank
    Outcome
    IncreaseStability of investigation behavior
    Study

    ratn = 95

    rats with chronic deprivation of serotonergic activity (neonatal 5,7-dihydroxytriptamine)
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    300 micrograms/kg · intracutaneousAs given in this study (rat).

    Source sentences

    Summary
    an increase in stability of investigation behavior
    1 context sentence
    Summary · context
    The effect of taftcine (Thr-Lys-Pro-Arg) and its analog TP-7 (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on rat behavior and serotonin brain exchange was studied in 95 adult male Wistar rats neonatally administered with 5,7-dihydroxytriptamine.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In rats with chronic serotonergic deprivation, TP-7 (Selank) normalized the serotonin level in the brain, as did taftcine.

    In plain wordsIn rats with low brain serotonin, Selank brought brain serotonin back to normal. Taftcine did the same.

    Peptide
    Selank
    Outcome
    Direction not reportedBrain serotonin level
    Study

    ratn = 95

    rats with chronic deprivation of serotonergic activity (neonatal 5,7-dihydroxytriptamine)
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    300 micrograms/kg · intracutaneousAs given in this study (rat).

    Source sentences

    Summary
    normalization of serotonin level in the brain
    1 context sentence
    Summary · context
    The effect of taftcine (Thr-Lys-Pro-Arg) and its analog TP-7 (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on rat behavior and serotonin brain exchange was studied in 95 adult male Wistar rats neonatally administered with 5,7-dihydroxytriptamine.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats with chronic serotonergic deprivation, the anxiolytic activity of TP-7 (Selank) was more pronounced than that of taftcine.

    In plain wordsIn rats with low brain serotonin, Selank reduced anxiety more strongly than taftcine.

    Peptide
    Selank
    Outcome
    IncreaseAnxiolytic activity compared with taftcine
    Study

    ratn = 95

    rats with chronic deprivation of serotonergic activity (neonatal 5,7-dihydroxytriptamine)
    Comparator
    Taftcine
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Anxiolytic and psychostimulant activities of TP-7 are more pronounced than those of tafcine.
    1 context sentence
    Summary · context
    The effect of taftcine (Thr-Lys-Pro-Arg) and its analog TP-7 (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on rat behavior and serotonin brain exchange was studied in 95 adult male Wistar rats neonatally administered with 5,7-dihydroxytriptamine.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats with chronic serotonergic deprivation, the psychostimulant activity of TP-7 (Selank) was more pronounced than that of taftcine.

    In plain wordsIn rats with low brain serotonin, Selank had a stronger stimulating effect than taftcine.

    Peptide
    Selank
    Outcome
    IncreasePsychostimulant activity compared with taftcine
    Study

    ratn = 95

    rats with chronic deprivation of serotonergic activity (neonatal 5,7-dihydroxytriptamine)
    Comparator
    Taftcine
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Anxiolytic and psychostimulant activities of TP-7 are more pronounced than those of tafcine.
    1 context sentence
    Summary · context
    The effect of taftcine (Thr-Lys-Pro-Arg) and its analog TP-7 (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on rat behavior and serotonin brain exchange was studied in 95 adult male Wistar rats neonatally administered with 5,7-dihydroxytriptamine.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.